Publications by authors named "Runyu Dong"

Claim this Profile
L
Lactylation-Driven HECTD2 Limits the Response of Hepatocellular Carcinoma to Lenvatinib.
Runyu Dong, Yao Fei, Yiren He, Peng Gao, Bo Zhang

Adv Sci (Weinh)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cuproptosis-related gene UBE2D2 functions as an immunotherapeutic and prognostic biomarker in pan-cancer.
Yao Fei, Danping Cao, Runyu Dong, Yanna Li, Zhixiong Wang

Clin Transl Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer.
Yao Fei, Danping Cao, Yanna Li, Zhixiong Wang, Runyu Dong

J Nanobiotechnology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer.
Yanna Li, Zhixiong Wang, Peng Gao, Danping Cao, Runyu Dong

J Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 'Other' subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma.
Runyu Dong, Zhixiong Wang, Danping Cao, Yanna Li, Yao Fei

IET Syst Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TH-302-loaded nanodrug reshapes the hypoxic tumour microenvironment and enhances PD-1 blockade efficacy in gastric cancer.
Zhixiong Wang, Menglin Zhu, Runyu Dong, Danping Cao, Yanna Li

J Nanobiotechnology· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis